Nalu Medical Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain

“Nalu Medical has made tremendous strides commercially and clinically in the past two years. Novo’s investment in Nalu reflects that progress and the confidence they share in the strong commercial potential for Nalu,” observed Geoff Pardo of Gilde Healthcare and Chairman of the Nalu Board.

Continue ReadingNalu Medical Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain